Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HCFC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BUB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUP98 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF155 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CD44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KANSL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RFC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C12orf29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAMK2D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM69A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL42 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR160 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BIN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBMXL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on